Company profile: UrSure
1.1 - Company Overview
Company description
- Provider of patient-friendly diagnostic tests that measure and improve adherence to medications, initially focused on drugs that prevent and treat HIV.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to UrSure
Sherlock Biosciences
HQ: United States
Website
- Description: Provider of engineering biology-based molecular diagnostics leveraging CRISPR and synthetic biology, including SHERLOCK for DNA/RNA detection and INSPECTR for instrument-free ambient tests, plus an FDA-authorized CRISPR SARS-CoV-2 kit. Offers global health partnerships to develop and distribute affordable infectious disease diagnostics and an internship & co-op program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sherlock Biosciences company profile →
Immtech Pharma
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics, focusing on the discovery and commercialization of treatments for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immtech Pharma company profile →
ISR Immune System Regulation
HQ: Sweden
Website
- Description: Provider of innovation-driven immunotherapy research, conducting preclinical and clinical studies to develop novel drugs for curative treatment of viral infections, based at the Karolinska Hospital in Stockholm, Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ISR Immune System Regulation company profile →
Poolbeg Pharma
HQ: Ireland
Website
- Description: Provider of clinical-stage research and development of novel treatments for infectious diseases, including POLB 001, an oral small molecule for cancer immunotherapy-induced cytokine release syndrome and severe influenza; AI-powered drug discovery leveraging human challenge trial data; and an oral GLP-1 agonist delivery system targeting obesity and other metabolic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Poolbeg Pharma company profile →
Spero Therapeutics
HQ: United States
Website
- Description: Provider of oral and IV antibiotic therapies for gram-negative infections: Tebipenem HBr for complicated urinary tract infections and acute pyelonephritis to reduce hospitalizations and support transition from IV to home care; SPR720, an oral investigational agent for nontuberculous mycobacterial pulmonary disease; and SPR206, an IV candidate for multidrug-resistant Gram-negative infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spero Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for UrSure
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to UrSure
2.2 - Growth funds investing in similar companies to UrSure
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for UrSure
4.2 - Public trading comparable groups for UrSure
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →